Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.

A new study, which has found that Covid-19, caused by the Sars-CoV-2 virus is linked to accelerated plaque buildup in the ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Konica Minolta Healthcare Americas, Inc., is pleased to announce the publication of a case study by clinicians in the ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Millions of South Africa are suffering with symptoms generally known as Long Covid. This growing crisis is shattering lives, ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.

Hi, I’m Dr. Robin Miller for HealthDay.  Is tuberculosis making a comeback in the U.S.? After three decades on the decline, TB rates in the U.S. have been steadily increasing since 2020. The state of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...